NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Enables Drug Fingerprinting via Unique HPLC/MS Salt Forms Method - Thermo Fisher Scientific, the world leader in serving science, today announced that it has developed a comprehensive method for the identification, confirmation and quantitation of illicit drugs and their salt forms (NYSE: TMO)
Thermo Fisher Scientific Enables Drug Fingerprinting via Unique HPLC/MS Salt Forms Method

 

NewswireTODAY - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2010/10/11 - Thermo Fisher Scientific, the world leader in serving science, today announced that it has developed a comprehensive method for the identification, confirmation and quantitation of illicit drugs and their salt forms (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This unique method combines high-performance liquid chromatography with mass spectrometry (HPLC/MS) to provide accurate simultaneous separation and detection of cations and anions in illicit drug salt forms. The technique enables drug salt forms to be precisely identified and confirmed by two independent parameters - retention time and mass spectral signature, allowing forensic drug chemists to reliably analyze seized materials. The method also enables pharmaceutical drug QA/QC analysts to determine counterfeit drugs and describe drug efficacy. The new method is detailed in an application note entitled “An Accurate and Robust LC/MS Method for the Identification of Illicit Drug Salt Forms.”

The World Drugs Report 2009 states that between 172 and 250 million people worldwide used illicit drugs at least once in 2007, with 18–38 million estimated to be heavy drug users. The illicit drug trade fuels crime and violence and inappropriate and extended use of any of these drugs can lead to devastating health outcomes. Illicit drugs are often encountered in the form of salts and identification of the specific counterion present may provide valuable information about the source of production and the manufacturing pathway. As a result, techniques to accurately screen and identify drugs, drug precursors and new drug derivatives are crucial to law enforcement efforts to curb the black market in controlled substances.

The new Thermo Scientific HPLC/MS method is a powerful alternative to other techniques currently being used to analyze illicit drugs and their salt forms. This method enables simultaneous determination of cations and anions with exceptional sensitivity, detection and accurate identification of a wider range of compounds without requiring derivitization, which in turn provides simultaneous qualitative and quantitative information on drug salt forms.

In this method, HPLC/MS analysis is performed on a Thermo Scientific Accela UHPLC system coupled to a Thermo Scientific MSQ Plus Mass Detector, a sensitive and fast scanning single quadrupole mass spectrometer. The Accela™ UHPLC system offers the flexibility of performing both conventional and high-speed LC separations on a single platform, while the rapid polarity switching capability of the MSQ™ Plus Mass Detector, together with its operational mass range, enables simultaneous detection of cations and anions in a single analysis.

For more information on the new Thermo Scientific HPLC/MS method for the identification, confirmation and quantitation of drug salt forms or to obtain a copy of the application note, please call +1 866-463-6522, email analyze[.]thermofisher.com.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. (thermoscientific.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Enables Drug Fingerprinting via Unique HPLC/MS Salt Forms Method

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Lindsay Baldry - Scottpr.com 
+44(0)14 7753 9539 thermo[.]scottpr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
Tongue-operated AI-powered Device that Aims to Challenge Neuralink, Wins Red Dot 2024 Award
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
Cancer Treatment Using Rotating Gantry of the Toshiba Heavy Ion Therapy System Starts At Yonsei University Health System
Bruker's Canopy Biosciences Announces the Launch of CellScape™ Whole-Slide Imaging Chamber for Spatial Biology
iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety Providing Quality Imaging & Diagnosis with its iSono Health ATUSA
Bruker Launches the New BEAM, a Dedicated Single-Point FT-NIR Spectrometer Designed for In-Process Control
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery At SLAS2024
Yokogawa Introduces CellVoyager High-Content Analysis System CQ3000
Advantech Introduces Cutting-Edge Solutions to Address Diverse Imaging Needs in Operating Rooms - The AVAS-2 Series for 4K Streaming Excellence
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis
Withings Announces BeamO The Revolutionary At-home Health Checkup
Advancing GLP-1 Treatments, Insulin, and Large-volume Injections with Ready-to-use Cartridges from SCHOTT Pharma
Sofwave Earns Frost & Sullivan’s 2023 NA Technology Innovation Leadership Award for Developing A Sophisticated Skin Tightening Ultrasound Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow, Inc.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)